Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact

SIMPLE SUMMARY: Resistance to antiangiogenic therapy represents a challenge in the therapeutic approach for hepatocellular carcinoma (HCC). The advent of immune checkpoint inhibitors (ICIs) seems to be a solution to this issue; however, other gaps have emerged since they have only been shown to prov...

Descripción completa

Detalles Bibliográficos
Autores principales: Federico, Piera, Giunta, Emilio Francesco, Tufo, Andrea, Tovoli, Francesco, Petrillo, Angelica, Daniele, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776845/
https://www.ncbi.nlm.nih.gov/pubmed/36551730
http://dx.doi.org/10.3390/cancers14246245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776845/
https://www.ncbi.nlm.nih.gov/pubmed/36551730
http://dx.doi.org/10.3390/cancers14246245

Ejemplares similares